Johnson & Johnson is working to develop modified versions of its COVID-19 vaccine

Johnson and Johnson is attempting to create adjusted versions of its COVID-19 vaccine that might be expected to secure against infection variations, a report said.

“We’re chipping away at a few next ages of vaccines,” J&J Chief Executive Alex Gorsky said Thursday during an online discussion, as per the media.

Gorsky communicated confidence that its present vaccine could offer some assurance against new COVID-19 strains.

Be that as it may, he said, “We must be readied,” the paper detailed. “We ought to plan for the most exceedingly terrible and pray fervently.”

Johnson and Johnson’s single-portion vaccine was endorsed by the US Food and Drug Administration in late February.

The FDA attested J&J’s tracking down that the vaccine was 66% powerful generally at warding off moderate and extreme COVID-19 cases and 85 percent successful at forestalling the most genuine diseases.